London Health Sciences Centre Uni Campus

London, Ontario N6A 5A5

1 studies enrolling now · 5 studies all time

What they study most

Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Relapsing-Remitting, Progressive Multiple Sclerosis (PMS)

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis — Running, not enrolling
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early